By Chance Scott bio The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition. When Congress … [Read more...]
FUNDING
Kailos, Huntsman Institute Receive NIH Grant to Develop Cancer Recurrence Test
June 27, 2016
By Ron Shinkman, Editor, Laboratory Industry Report The Alabama-based Kailos Genetics and the Huntsman Cancer Institute at the University of Utah have received a $2.4 million grant from the … [Read more...]
ID Genomics Receives $3 Million NIH Grant to Develop Antibiotics Screening Test
May 19, 2016
Seattle-based startup laboratory ID Genomics has received a nearly $3 million federal grant to compile a database of antibiotic resistant bacteria. The three-year grant from the National Institutes … [Read more...]
FUNDING
ID Genomics Receives $3 Million NIH Grant to Develop Antibiotics Screening Test
May 19, 2016
Seattle-based startup laboratory ID Genomics has received a nearly $3 million federal grant to compile a database of antibiotic resistant bacteria. The three-year grant from the National Institutes … [Read more...]
FUNDING
Quanterix Raises $46 Million to Fuel Expansion of Clinical Diagnostics
March 28, 2016
By Stephanie Murg, Managing Director, G2 Intelligence A fresh infusion of capital is set to fuel continued growth at Quanterix Corporation (Lexington, Mass.), which specializes in "high-definition … [Read more...]
Sequenom Remakes Fiscal, Operational House
February 1, 2016
Struggling to remake its fiscal house and gain some traction, Sequenom is putting its laboratory in North Carolina on the blocks and will cut its total workforce by more than 20 percent. Sequenom, … [Read more...]
Sequenom Remakes Fiscal, Operational House
January 21, 2016
Struggling to remake its fiscal house and gain some traction, Sequenom is putting its laboratory in North Carolina on the blocks and will cut its total workforce by more than 20 percent. Sequenom, … [Read more...]
NantOmics Acquires OncoPlex Diagnostics
September 17, 2015
A diagnostic firm connected with a Los Angeles billionaire making a run to remake cancer care has acquired a Maryland-based clinical laboratory that specializes in testing tumor cell … [Read more...]
Exosome Raises Second Round Funding, Close to Launching Cancer Tests
September 17, 2015
Exosome Diagnostics has continued on its capital raising roll, bringing in another $17.6 million in financing, and its series B total to $44.7 million. The latest round was funded by Forbion Capital … [Read more...]
Cynvenio Raises Capital, Enters Into Pact With Cancer Patient Exchange Firm
July 2, 2015
Cynvenio Biosystems has raised $35.5 million in second-round private equity funding and has struck an agreement with another company to help place its patients into clinical trials. The funding for … [Read more...]
